INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

78,613 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
GJ
Goldman JonathanDirector
AVTXAvalo Therapeutics, Inc.
Option exercise
M—
3,166 sh
Mar 28, 2026Mar 31, 2026
Page 1252 of 1966
← PrevNext →
traded Mar 28, 2026
+3d
SEC Form 4

Evidence

5
PE
Palomaki EricChief Operating Officer
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$39K
2,035 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
CJ
Crocker Mary JayneDirector
BWBBridgewater Bancshares Inc
Grant or award
A—
280 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

5
GJ
Gayford Michael JamesEVP of Operations
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$7,760
400 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
MA
Merriman AndrewChief Operating Officer
CTMCastellum, Inc.
Grant or award
A$604
1,329 sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

5
SJ
Stenberg JonDirector, President & CEO
CIACITIZENS, INC.
Tax withholding
F$23K
4,946 sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

5
PE
Palomaki EricChief Operating Officer
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$15K
807 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
PE
Palomaki EricChief Operating Officer
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$48K
2,549 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
PE
Palomaki EricChief Operating Officer
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$35K
1,748 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
SJ
Stenberg JonDirector, President & CEO
CIACITIZENS, INC.
Option exercise
M—
20.3K sh
Mar 28, 2026Mar 31, 2026
traded Mar 28, 2026
+3dSEC Form 4

Evidence

5
GJ
Gayford Michael JamesEVP of Operations
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$1,979
102 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
GJ
Gayford Michael JamesEVP of Operations
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$19K
962 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

5
GJ
Gayford Michael JamesEVP of Operations
CMTCORE MOLDING TECHNOLOGIES INC
Tax withholding
F$14K
725 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

4
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
14.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

4
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
5,649 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$49K
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

2
LJ
Locascio Dirk J.EVP, Chief Financial Officer
USFDUS Foods Holding Corp.
Gift · 10b5-1 plan
G—
85.5K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$132K
1,792 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$96K
5,649 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

57
SB
Schimmelpennink Evert B.Director, President, CEO and Secretary
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$251K
28.1K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

52
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$300K
12.8K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

51
GP
George Jeffrey P.Director
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$50K
5,592 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
JM
Jansen John MDirector
OKLOOklo Inc.
Open-market sale
SELL$541K
10.5K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
CR
Chevallard Daniel R.Chief Financial Officer
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$64K
7,500 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

49
GD
Golub DavidDirector, CEO and Chairman, 10% Owner
NONENONEGolub Capital Private Income Fund I
Open-market purchase
BUY$12.50M
511.2K sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

49
SW
Sheehan William W IIEVP, CHIEF FINANCIAL OFFICER
ROSTROSS STORES, INC.
Open-market sale
SELL$1.06M
4,883 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

44
AD
Aguirre DeAnneDirector
HTGCHercules Capital, Inc.
Open-market purchase
BUY$105K
7,317 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

43
GP
Griscom PaulSVP and Controller
MMacy's, Inc.
Open-market sale
SELL$52K
2,919 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$1.49M
467.0K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$84K
4,712 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence